Intervention not reported
Mortality or CLD at 28/30 days · preterm infants
The intervention showed no clear difference in mortality or CLD at 28/30 days (low certainty).
1 finding from 1 review
Intervention not reported
Mortality to 28 days · preterm infants
It is very uncertain whether the intervention changes mortality to 28 days (very low certainty).
1 finding from 1 review
Intervention not reported
CLD at 28 days · preterm infants
The intervention showed no clear difference in CLD at 28 days (low certainty).
1 finding from 1 review
Intervention not reported
CLD among survivors to 28 days · preterm infants
The intervention showed no clear difference in CLD among survivors to 28 days (low certainty).
1 finding from 1 review
Intervention not reported
Days on mechanical ventilation · preterm infants
1 finding from 1 review
Number of episodes of regurgitation or vomiting per day · Formula‐fed healthy term infants up to 6 months of age with gastro‐oesophageal reflux
1 finding from 1 review
BPD at 28 days · neonates up to 44 weeks' postmenstrual age
Volume‐targeted showed no clear difference in BPD (supplemental oxygen at 28 days) compared with pressure‐limited ventilation: additional findings (low certainty).
1 finding from 1 review
Duration of positive pressure ventilation (days) · neonates up to 44 weeks' postmenstrual age
1 finding from 1 review
Death or BPD (28 days) · neonates up to 44 weeks' postmenstrual age
Volume‐targeted showed no clear difference in death or BPD (28 days) compared with pressure‐limited ventilation: additional findings (low certainty).
1 finding from 1 review
Patient readmissions · adults and children with acute exacerbation of asthma
MgSO4 + SABA + ipratropium showed no clear difference in readmission (7 to 30 days) compared with SABA + ipratropium (low certainty).
1 finding from 1 review
Mortality (in‐hospital death and 30‐day mortality) · adults receiving intravenous fluids whilst undergoing any form of surgery
Buffered showed no clear difference in mortality (in‐hospital death and 30‐day mortality) compared with non‐buffered crystalloid intravenous fluid (low certainty).
1 finding from 1 review
Length of hospital stay · Patients admitted to hospital with acute hypercapnic respiratory failure due to an exacerbation of chronic obstructive pulmonary disease…
1 finding from 1 review
Health service outcomes: 5. Days in community to first admission by 12 months · people with severe mental disorders
1 finding from 1 review
Service use: 1. Average number of days in hospital per month ‐ by about 24 months · people with severe mental disorders
1 finding from 1 review
Health service outcomes: 2. Hospital bed‐days by 12 months · people with severe mental disorders
1 finding from 1 review
Pain postoperative day 1 № of participants: 538 (6 studies) · patients requiring tonsillectomy (any diagnosis)
1 finding from 1 review
no estimate extracted
Studies not reported
Very low
Pain postoperative day 3 № of participants: 401 (5 studies) · patients requiring tonsillectomy (any diagnosis)
1 finding from 1 review
no estimate extracted
Studies not reported
Very low
Pain postoperative day 7 № of participants: 420 (5 studies) · patients requiring tonsillectomy (any diagnosis)
1 finding from 1 review
no estimate extracted
Studies not reported
Low
Artificial airway occlusion (measured over 3‐15 days (median 4 days)) · ventilated adults (18 trials) and children (1 trial)
Heat and moisture exchangers (HME) showed no clear difference in artificial airway occlusion (measured over 3‐15 days (median 4 days)) compared with heated humidifiers (HH) (low certainty).
1 finding from 1 review
All‐cause mortality, over the course of the study · ventilated adults (18 trials) and children (1 trial)
Heat and moisture exchangers (HME) showed no clear difference in mortality ‐ all cause (Measured over 3‐15 days (median 8 days)) compared with heated humidifiers (HH) (low certainty).
1 finding from 1 review